期刊文献+

破伤风类毒素对甲型副伤寒脱毒脂多糖的免疫增强作用

The function of of S.paratyphoid A-tetanus toxoid's immunity enhancement to the detoxified lipopolysaccharide
下载PDF
导出
摘要 目的增强多糖抗原在婴幼儿中的免疫原性,提供有效的免疫保护。方法采用液体培养,收集菌体,脂多糖(LPS)提取,纯化脂多糖,活化脱毒多糖(O-SP)与破伤风类毒素(TT)共价结合。ELISA法检测O-SP及结合物的免疫效果。结果单纯甲型副伤寒脱毒脂多糖未能诱导小鼠产生抗体,而与TT结合后,具有良好的免疫原性,能产生体液免疫反应,诱导小鼠产生较高水平的抗脂多糖抗体和抗破伤风抗体。结论破伤风类毒类对甲型副伤寒脱毒脂多糖具有免疫增强作用。 Objective To increase the immunognicity of detoxified lipopolysaccharide in infantile in order to provide stronger protection.Methods The detoxified lipopolysaccharide(LPS) antigen was obtained and purified from S.Paratyphi A strain which was multiplicated by submerged culture.The O-SP was covalent bond to the TT.The immunity effect was detected by ELISA.Results The IgG antibodies were not detected in the serum of mice immunized by detoxified lipopolysaccharide of S.Paratyphi A alone.The conjugate composed of detoxified LPS and tetanus toxoid elicited high anti-LPS IgG and anti-TT IgG level.Conclusion S.paratyphoid A-tetanus has immunity enhancement to the detoxified lipopolysaccharide.
出处 《中国实用医药》 2011年第7期17-18,共2页 China Practical Medicine
关键词 甲型副伤寒脱毒脂多糖 破伤风类毒素 免疫原性 S.paratyphoid A Tetanus toxoid Immunogenicity
  • 相关文献

参考文献5

二级参考文献11

  • 1王志高,周伟忠,史鉴,王同来.伤寒Vi多糖菌苗流行病学效果观察[J].中华流行病学杂志,1997,18(1):26-29. 被引量:25
  • 2金冬雁 黎孟枫译.分子克隆实验指南(第二版)[M].北京:科学出版社,1998.880-887.
  • 3王秉瑞 中华医学会 中华医学杂志编辑委员会.伤寒Vi多糖菌苗的免疫效果及免疫策略 《全国人用疫苗临床应用学会议》[J].中国桂林,1997,:59-63.
  • 4Ivanoff B.Levine M M,Lambert P H,Vaccination against typhoid fever.present statos.Bull WHO,1994:72:957-971.
  • 5Keitel W A,Bond N L.Zahradnik J M ,et al.Clinical and serological responses following primary and booster immunizstion with Salmonella thphi Vi capsular polysaocharide vaccines.Vaccine,1994,12:195-199.
  • 6Klugman K P,KoornHOF H J ,Robbins J B,et al.immunogencity,efficacy and serological correlate of protection of Salmomella typhi Vi capsular polysaccharide vaocine three years after immunization.Vsccine,1996:14:435-438.
  • 7Acharya I L.Lowe Cu,Thapa R,et al.Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella thphi.N Engl J Med,1987,317:1101-1104.
  • 8Klugman K P,Gilbertson I T,koomhof H J ,et al.Protective activity of Vi capsular phsaccharide vaccine againat typhoid fever,Lanoet,1987,ii,1165-1169.
  • 9Hohman E L.Oletta C A,Killen K P,et al.phop/phoQ-deleted Salonella tyhi (Ty800) in a safe and immunogemic single-dose tyhoid fever vsccine in vohmteers.J Infect Dis,1996,173:1408-1414.
  • 10Hohmann E L.Oletta C A,miller S I,Evafuation of a phoP/phpQ-deleted,aroA-edleted live oral Salmonella typhi vaccice strain in human volunteers.Vaccine,1996,14:19-24.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部